US · Healthcare · Medical Devices
EPS came in at -0.45 against a street estimate of -0.56 — a beat of 19.6%.
Analysts rate Quanterix Corp a hold (0 buy, 3 hold, 0 sell out of 3) with an average price target of $3.00.
| Fund | Stake |
|---|---|
| Arnhold & S. Bleichroeder Advisers, LLC | 11.64% |
| BlackRock Inc | 7.69% |
| Ameriprise Financial Inc | 7.49% |
| Blue Water Life Science Advisors, LLC | 7.35% |
| Portolan Capital Management, LLC | 4.02% |
| Vanguard Capital Management, LLC | 3.81% |
| Lionhunter Capital Management, LLC | 3.17% |
| AQR Capital Management LLC | 2.84% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Quanterix Corp — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.